News | Stents | January 22, 2019

Coronary Stent Market Characterized by New Drug-eluting Stents

India to come up as a lucrative growth ground by 2024

The Indian-made SMT SuperFlex stent. SMT has been developing stents and other interventional products designed to be a more affordable, home-grown option for the growing Indian market.

The Indian-made SMT SuperFlex stent. SMT has been developing stents and other interventional products designed to be a more affordable, home-grown option for the growing Indian market.

The rise cardiovascular disease has been instrumental in fueling the coronary stent market share in the past few years. Sedentary lifestyle and a drastic change in dietary patterns have led to a surge in heart-related disorders across the globe. The demand for coronary stents has been increasing, which has encouraged medical devices and equipment manufacturers to focus on creating affordable and sustainable products to garner a competitive edge over rivals. The growing utilization of drug-eluting stents (DES) and biodegradable polymer-coated coronary stents is expected to propel the growth potential of coronary stents in the years ahead. This is according to a new report by Global Market Insights Inc., a global market research and consulting service provider. 

 

Overview Major Advancements in Drug-eluting Stents

One of the most prominent challenges faced by clinical physicians and cardiologists during the percutaneous coronary intervention (PCI) is the prevalence of complex vasculatures or lesions in small vessels of patients suffering from coronary artery ailment. Significantly, about 65 percent of smaller vessels are situated in difficult-to-reach areas of the heart, which invariably makes it difficult to treat lesions.

Considering these challenges, the Ireland-based coronary stents market leader Medtronic has recently introduced the Resolute Onyx 2.0 mm Drug-Eluting Stent. The FDA-approved, high-grade stent is the smallest sized drug eluting stent currently available on the market and is specifically designed for small vessels, which are often untreatable with bigger stents during percutaneous coronary intervention (PCI) procedures. Moreover, the new stent could further assist interventional cardiologists in treating coronary artery diseases more effectively.

In order to overcome the limitations of bare metal stents, numerous companies in the coronary stent industry have been focusing on developing DES coated with biodegradable polymers. For instance, the India-headquartered medical devices company SMT has recently unveiled an advanced DES system called the Supralimus Grace, which has been equipped with a biodegradable polymer coating and features fourth generation design. It has also been further improvised for low deflation profile to retrieve the delivery system after dilation of the stent. 

Companies have been proactive in developing DES coated with biodegradable polymers to enhance clinical outcomes. Consequentially, this has assisted coronary stents market players to focus on research and tap into new business opportunities being opened up across various geographies.

One issue holding back further market expansion of coronary stents in the developing world is that the majority of stent procedures are paid out of pocket. The exorbitant prices of advanced coronary stents has always been a cause of concern in these countries. 

Growing prevalence of coronary artery disease, which is one of the major causes of mortality, along with higher prices of stents have been crucial factors that have compelled various regulatory agencies to boost the availability of affordable coronary stents across their respective countries. The National Pharmaceutical Pricing Authority of India (NPPA), for instance, reduced the prices of DES in February 2018. The goal of pricing control is to increase demand for coronary stents. Growing per-capita income and healthcare expenditure could further contribute toward the growth prospects for the Indian coronary stents market. Global Market Insights reports the Indian coronary stent industry is projected to expand at a CAGR of 11.9 percent over the estimated time by 2024.

The swift-paced technological innovations with regards to the development of high-grade coronary stents and concerted efforts by various medical devices manufacturers to create stents that are user-friendly could fuel market expansion. In addition to this, a favorable regulatory framework across emerging nations would benefit the profile of the  coronary stentmarket, which is cexpected to exceed $11.9 billion by the year 2024.

For more information: www.gminsights.com/industry-reports/healthcare-and-medical-devices

 

Related Stent Trends Articles:

New Directions and Trends in Coronary Metallic Stents

New Peripheral Stent Technology

The Next Step in Bioresorbable Stent Technologies

Related Content

Philips angiography system in a cath lab at Henry Ford Hospital.
Feature | Cardiovascular Business | July 13, 2020 | Deb Thompson and Christian Comeau
For a cardiovascular service line leader, addressing challenges in an evolving healthcare climate is a constant.
Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

News | Cardiovascular Business | July 08, 2020
July 8, 2020 – Philips Healthcare and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service agree
Medicare will pay for telehealth virtual doctor visits during the duration of the coronavirus COVID-19 outbreak.
News | Cardiovascular Business | March 17, 2020
March 17, 2020 — The Trump Administration today announced expanded Medicare telehealth coverage that will enable bene
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Cardiovascular Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
 Cath Lab Philips Azurion angiography PCI
News | Cardiovascular Business | December 30, 2019
December 30, 2019 — Most patients do not understand or recall information given to them before heart procedures.
Siemens Healthineers Acquires ECG Management Consultants
News | Cardiovascular Business | November 11, 2019
November 11, 2019 — ECG Management Consultants, a leading U.S.
Videos | Cardiovascular Business | September 30, 2019
A discussion with Ruth Fisher, MBA, vice president of the...
Scranton Gillette Communications Names Diagnostic and Interventional Cardiology Group Publisher and Integrated Media Consultant

Diane Vojcanin (left) was named vice president, group publisher, healthcare group, overseeing Imaging Technology News (ITN) and Diagnostic and Interventional Cardiology (DAIC). Andreja Slapsys (right) was named a healthcare group integrated media consultant.

News | Cardiovascular Business | September 06, 2019
Business-to-business communications company Scranton Gillette Communications has named Diane Vojcanin as vice president...